The role of sentinel lymph node biopsy in the management of thin melanoma.

The lifetime risk for developing thin (< or =1 mm) melanoma continues to increase steadily. Although generally associated with an excellent prognosis, it also has a proven capacity to metastasize. There has been increasing interest in using sentinel lymph node biopsy to improve staging for thin melanoma. However, it is difficult to define clinicopathologic factors that reliably predict the presence of nodal metastasis. The prognostic significance of a positive sentinel lymph node in thin melanoma remains to be defined.

[1]  L. Ferreira,et al.  Vertical growth phase and positive sentinel node in thin melanoma. , 2003, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[2]  A. Jemal,et al.  Cancer Statistics, 2004 , 2004, CA: a cancer journal for clinicians.

[3]  D. Morton,et al.  Role of sentinel lymphadenectomy in thin invasive cutaneous melanomas. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  M. Lens,et al.  Tumour thickness as a predictor of occult lymph node metastases in patients with stage I and II melanoma undergoing sentinel lymph node biopsy , 2002, The British journal of surgery.

[5]  W. McCarthy,et al.  Prognosis for patients with thin cutaneous melanoma , 2003, Cancer.

[6]  D. Tyler,et al.  Thin Melanomas: Predictive Lethal Characteristics From a 30-Year Clinical Experience , 2003, Annals of surgery.

[7]  D L Morton,et al.  Technical details of intraoperative lymphatic mapping for early stage melanoma. , 1992, Archives of surgery.

[8]  S. McCarthy,et al.  Thin malignant melanomas and recurrence potential. , 1987, Archives of surgery.

[9]  D. Weaver,et al.  Minimal-access surgery for staging of malignant melanoma. , 1995, Archives of surgery.

[10]  M. Walker,et al.  Cost-effectiveness of sentinel lymph node biopsy in thin melanomas. , 2003, Surgery.

[11]  C. Bunker,et al.  Clinico‐pathological features of relapsing very thin melanoma , 2001, Clinical and experimental dermatology.

[12]  D. Rigel,et al.  Malignant melanoma: Prevention, early detection, and treatment in the 21st century , 2000, CA: a cancer journal for clinicians.

[13]  Claus Garbe,et al.  Prognostic factors of thin cutaneous melanoma: an analysis of the central malignant melanoma registry of the german dermatological society. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  D. Krag,et al.  Sentinel lymph node biopsy for melanoma. , 1998, American journal of surgery.

[15]  J. J. Coleman,et al.  Sentinel Lymph Node Biopsy for Melanoma: Experience with 234 Consecutive Procedures , 2000, Plastic and reconstructive surgery.

[16]  David Elder,et al.  Thin primary cutaneous malignant melanoma: a prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer staging. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  Jeffrey E. Lee,et al.  Revised American Joint Committee on Cancer Staging Criteria Accurately Predict Sentinel Lymph Node Positivity in Clinically Node-Negative Melanoma Patients , 2003, Annals of Surgical Oncology.

[18]  A. Dobozy,et al.  Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas , 2003, The British journal of dermatology.

[19]  M. Ross,et al.  Complications Associated With Sentinel Lymph Node Biopsy for Melanoma , 2003, Annals of Surgical Oncology.

[20]  Jeremy MG Taylor,et al.  Mitotic Rate and Younger Age Are Predictors of Sentinel Lymph Node Positivity: Lessons Learned From the Generation of a Probabilistic Model , 2004, Annals of Surgical Oncology.

[21]  A. Alavi,et al.  Incidence of Sentinel Node Metastasis in Patients With Thin Primary Melanoma (#1 mm) With Vertical Growth Phase , 2000, Annals of Surgical Oncology.

[22]  A. Stromberg,et al.  Correlation Between Prognostic Factors and Increasing Age in Melanoma , 2004, Annals of Surgical Oncology.

[23]  M. S. Blois,et al.  The regressing thin malignant melanoma. A distinctive lesion with metastatic potential , 1978, Cancer.

[24]  N Cascinelli,et al.  Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.